Follow
Katia Yu La Rosa
Katia Yu La Rosa
Department of Experimental Medicine and Surgery, University of Rome “Tor Vergata”, Rome, Italy
No verified email
Title
Cited by
Cited by
Year
Epidemiological characterization of SARS-CoV-2 variants in children over the four COVID-19 waves and correlation with clinical presentation
C Alteri, R Scutari, V Costabile, L Colagrossi, K Yu La Rosa, E Agolini, ...
Scientific reports 12 (1), 10194, 2022
232022
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C
VC Di Maio, S Barbaliscia, E Teti, G Fiorentino, M Milana, S Paolucci, ...
Liver International 41 (8), 1802-1814, 2021
142021
Cryptic HBV replicative activity is frequently revealed in Anti-HBc-positive/HBsAg-negative patients with HIV infection by highly sensitive molecular assays, and can be …
R Salpini, V Malagnino, L Piermatteo, T Mulas, M Alkhatib, R Scutari, ...
Microorganisms 8 (11), 1819, 2020
92020
A hyper-glycosylation of HBV surface antigen correlates with HBsAg-negativity at immunosuppression-driven HBV reactivation in vivo and hinders HBsAg recognition in vitro
R Salpini, L Piermatteo, A Battisti, L Colagrossi, M Aragri, K Yu La Rosa, ...
Viruses 12 (2), 251, 2020
82020
Key mutations in the C-terminus of the HBV surface glycoprotein correlate with lower HBsAg levels in vivo, hinder HBsAg secretion in vitro and reduce HBsAg …
R Salpini, A Battisti, L Piermatteo, L Carioti, OE Anastasiou, US Gill, ...
Emerging Microbes & Infections 9 (1), 928-939, 2020
72020
Genetic determinants in a critical domain of NS5A correlate with hepatocellular carcinoma in cirrhotic patients infected with HCV genotype 1b
M Alkhatib, VC Di Maio, V De Murtas, E Polilli, M Milana, E Teti, ...
Viruses 13 (5), 743, 2021
32021
Presence of resistance associated variants in patients with virological failure to new direct acting antivirals and requirement of unconventional regimens for re-treatment
VC Di Maio, V Cento, D Di Paolo, I Lenci, M Aragri, G Verucchi, M Melis, ...
Digestive and Liver Disease 1 (48), e3-e4, 2016
22016
Prevalence of Epstein-Barr Virus infection in a cohort of onco-hematologic paediatric patients
L Colagrossi, LF Rodriguez, L Coltella, S Ranno, G Linardos, VC Di Maio, ...
Microbiologia Medica 38 (1), 2023
2023
Publisher Correction: Epidemiological characterization of SARS-CoV-2 variants in children over the four COVID-19 waves and correlation with clinical presentation
C Alteri, R Scutari, V Costabile, L Colagrossi, KY La Rosa, E Agolini, ...
Scientific Reports 12, 2022
2022
Cryptic HBV viremia in anti-HBC positive/HBsAg negative patients with HIV infection is frequently revealed by applying an ultrasensitive droplet digital PCR assay
R Salpini, V Malagnino, M Alkhatib, L Piermatteo, R Scutari, R Chirichiello, ...
Journal of Hepatology 73, S844, 2020
2020
Resistance and phylogenetic analysis in HCV-2c infected patients within the Italian network VIRONET-C
VC Di Maio, S Barbaliscia, L Fabeni, E Teti, S Paolucci, C Minichini, ...
Journal of Hepatology 73, S336-S338, 2020
2020
Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C
S Barbaliscia, VC Di Maio, L Fabeni, E Teti, S Paolucci, C Minichini, ...
Digestive and Liver Disease 52, e24-e25, 2020
2020
Clinical relevance of accurate HCV genotype and subtype assignment by NS3/NS5A/NS5B direct sequencing in the era of new direct acting antiviral agents
M Aragri, VC Di Maio, D Di Paolo, V Cento, F De Leonardis, L Gianserra, ...
Digestive and Liver Disease 48, e1-e2, 2016
2016
Fast and deep early HCV-RNA decay is accompanied by fast aminotransferases normalization values in cirrhotic HCV-1 patients treated with paritaprevir/r-ombitasvir and dasabuvir …
V Cento, E Teti, E Biliotti, F Fiore, F Antonucci, M Aragri, C Magni, ...
HEPATOLOGY 62, 323A-324A, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–14